Skip to main content

Want a detailed portfolio tracker?

Moderna (MRNA) P/E (2018 - 2026)

Moderna (MRNA) P/E from Dec 31, 2018 to Jun 3, 2026. The TTM Moderna (MRNA) P/E is -6.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Moderna (MRNA)

YearP/EChange
2026-6.05+48.44%
2025-4.07-9.20%
2024-4.49-58.77%
2023-10.88-278.86%
20226.08-27.53%
20218.40-115.32%
2020-54.81+334.04%
2019-12.63-64.43%
2018-35.50N/A

Comparison Moderna (MRNA) P/E with competitors

Moderna (MRNA) P/E is -6.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.69%
ENLVEnlivex Therapeutics Ltd0.15-102.48%
FGENFibroGen Inc0.24-103.97%
TRAWTraws Pharma Inc0.47-107.82%
FBIOFortress Biotech Inc0.71-111.67%
CHRSCoherus Biosciences Inc0.98-116.17%
ORMPOramed Pharmaceuticals Inc1.47-124.36%
AGENAgenus Inc2.05-133.87%
VIVSVivoSim Labs Inc2.54-141.93%
INVAInnoviva Inc3.19-152.72%
CRMDCorMedix Inc3.65-160.28%
ABEOAbeona Therapeutics Inc4.20-169.52%
VXRTVaxart Inc4.26-170.46%
CVACCureVac N.V.4.45-173.50%
SRPTSarepta Therapeutics Inc4.62-176.46%
GLPGGalapagos NV4.86-180.33%
RIGLRigel Pharmaceuticals4.92-181.34%
ZVRAZevra Therapeutics Inc4.97-182.24%
ABUSArbutus Biopharma Corp5.69-194.14%
CGENCompugen Ltd7.38-222.08%
AUPHAurinia Pharmaceuticals Inc9.25-252.96%
ACADAcadia Pharmaceuticals Inc9.59-258.53%
OMEROmeros Corporation9.88-263.41%
PLXProtalix BioTherapeutics Inc9.91-263.84%
SPROSpero Therapeutics Inc10.73-277.49%
ADMAAdma Biologics Inc11.33-287.34%
SVASinovac Biotech Ltd11.44-289.08%
TBPHTheravance Biopharma Inc11.78-294.71%
HRMYHarmony Biosciences Holdings Inc12.18-301.39%
TGTXTG Therapeutics Inc13.18-317.91%
INCYIncyte Corp13.38-321.26%
SABSSAB Biotherapeutics Inc14.06-332.43%
XOMAXOMA Corp14.95-347.10%
REGNRegeneron Pharmaceuticals Inc14.98-347.68%
PBYIPuma Biotechnology Inc15.05-348.84%
EXELExelixis Inc15.79-361.15%
NAGENiagen Bioscience Inc16.35-370.41%
CPRXCatalyst Pharmaceuticals Inc17.34-386.78%
MDXGMimedx Group Inc17.38-387.28%
ARGXArgen X SE23.07-481.47%
HALOHalozyme Therapeutics Inc23.20-483.60%
XOMAOXOMA Corp25.34-519.05%
VRTXVertex Pharmaceuticals Inc25.66-524.19%
XOMAPXOMA Corp25.67-524.43%
CTMXCytomX Therapeutics Inc25.70-524.89%
ASNDAscendis Pharma A/S26.35-535.74%
RPRXRoyalty Pharma plc - Class A27.50-554.61%
SLNOSoleno Therapeutics Inc29.02-579.74%
LGNDLigand Pharmaceuticals Inc - Class B30.19-599.10%
BMRNBiomarin Pharmaceutical Inc37.51-720.15%
APLSApellis Pharmaceuticals Inc39.02-745.18%
KRYSKrystal Biotech Inc39.70-756.36%
GMABGenmab40.20-764.73%
ONCBeiGene Ltd67.03-1208.23%
TECHBio-Techne Corp68.59-1234.15%
VCELVericel Corp80.63-1433.13%
PHARPharming Group N.V.87.74-1550.70%
ALNYAlnylam Pharmaceuticals Inc124.93-2165.66%
TLXTelix Pharmaceuticals Ltd139.89-2412.96%
CORTCorcept Therapeutics Inc158.39-2718.81%